Stock Analysis of Prenetics HLDG Co Ltd. WT (PRENW) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code PRENW
Close 0.0067
Change -0.0002 / 2.90 %
Volume 542.00
Vol Change -169037.00 / 99.68 %
IndustryDiagnostics & Research
SectorHealthcare
AIO Strength Index
Technical StrengthNeutral
Growth Index Good Growth
Value Index Very Low Value Stock
Profitability Index Poor Profitability Stock
Stability Index No Significant Stability


Fundamental View of Prenetics HLDG Co Ltd. WT
PE (TTM)

-0.0044

Very Poor
Price / Book

0.0015

Excellent
Price / Sales

0.0152

Excellent
Piotroski F Score

2.0

Poor
Market Cap

0

Enterprise Value

0

ROA (TTM)

-27.08

Very Poor
ROE (TTM)

-33.99

Very Poor
Net Margin (TTM)

-343.04

Very Poor
Revenue

1.41 %

279640 K
Net Profit

76.81 %

-44168.52 K
Debt to Equity

0.078

Excellent
Altman Z Score

-1.87

Very Poor
Quick Ratio

2.08

Good
Cash Ratio

1.84

Indecisive


Highs/Lows of Prenetics HLDG Co Ltd. WT
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.0075 10.67 % 0.513 % 0.00740.006728-May-2429-May-24
Two Week0.0075 10.67 % 0.486 % 0.00740.006728-May-2429-May-24
One Month0.0075 10.67 % 4.80 % 0.00750.005808-May-2406-May-24
Three Month0.0062 8.06 % 3.56 % 0.020.005104-Mar-2422-Apr-24
Six Months0.0075 10.67 % 15.54 % 0.0250.014-Feb-2401-Feb-24
One year0.1187 94.36 % 26.26 % 0.13580.026-Jun-2301-Feb-24
Two year0.398 98.32 % 27.72 % 0.63580.022-Sep-2201-Feb-24


Technical View of Prenetics HLDG Co Ltd. WT
RSI

46.67

Neutral
MACD

-0.0002

Bearish
ADX

22.87

Neutral
Super Trend

0.0051

Mild Bullish
Williams %R

-63.64

Neutral
CCI

-46.80

Neutral


EMA 5

0.0069

Strong Bearish
EMA 15

0.0072

Neutral
EMA 50

0.0089

Mild Bearish
EMA 100

0.0223

Mild Bearish
SMA 100

0.0101

Mild Bearish
SMA 200

0.053

Mild Bearish
SMA 5 / 20

0.0068 / 0.0074

Strong Bearish
SMA 15 / 50

0.0076 / 0.0076

Neutral
SMA 50 / 200

0.0076 / 0.053

Mild Bearish




Charts of Prenetics HLDG Co Ltd. WT


Returns of Prenetics HLDG Co Ltd. WT with Peers
Period / StockPRENWBIOCHTGMQSAMUTRS
1 Week-10.67%-14.89%-13.48%2.60%0%
1 Mth-10.67%-68.94%-75.56%12.16%-99.82%
3 Mth8.06%-70.01%-82.92%55.14%-99.88%
6mth-10.67%44.82%-88.77%59.62%-99.97%
1 Year-94.36%-41.23%-97.00%38.91%-99.98%
2 Year-98.32%-88.79%-99.37%43.10%-100.00%
5 Years--97.95%-99.93%2113.33%-
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Prenetics HLDG Co Ltd. WT with Peers
Ratio / StockPRENWBIOCHTGMQSAMUTRS
PE-0.0044-2.57-0.079-5.01-0.0232
P/B0.00157.120.794-49.990.051
ROA-27.08-114.74-175.05-576.91-66.79
ROE-33.99-276.93-562.450-217.71
Debt To Equity0.0780.1960.5370.04600
Revenue279640 K
1.41 % 		25858.00 K
5.84 % 		6366.22 K
28.52 % 		0
% 		51693.00 K
2.78 %
Net Income-44168.52 K
76.81 % 		-32087.00 K
80.19 % 		-21594.48 K
25.95 % 		-5085.07 K
16.29 % 		-33450.00 K
1.94 %


Technicals of Prenetics HLDG Co Ltd. WT with Peers
Technical / StockPRENWBIOCHTGMQSAMUTRS-
ADX22.8725.3835.6724.4335.70
CMF-0.522-0.258-0.3860.4950.0444
MFI68.8878.778.5166.662.82
RSI46.6728.0318.0068.6930.41
MACD Abv SignalFalseFalseFalseFalseFalse
Price Above 50 MAFalseFalseFalseTrueFalse-
Price Above 200 MAFalseFalseFalseTrueFalse-


About : Prenetics Holding Company Limited

Address : Unit 701-706, Quarry Bay, Hong Kong
Tel : 852 2210 9588
URL : https://www.prenetics.com
Code : PRENW, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 18_May_2022
Employee Count : 320

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment in Taiwan, Hong Kong, the United Kingdom, and internationally. It operates through two segments: Prevention and Diagnostics. The company offers CircleDNA, a consumer genetic testing product to offer comprehensive DNA test. It also provides Insighta develops and commercializes multi-cancer early detection technology named Fragma. In addition, the company, through acquisition of ACT Genomics, which is involved in genomic profiling of panels through ACTOnco, ACT HRD, ACTFusion, and ACTDrug. Further, the company offers ACTLiquid Pro, an NGS-based liquid biopsy assay for pan-solid tumors; ACTMonitor which provides realtime monitoring of drug resistance, treatment response, and cancer recurrence; and ACT Risk which manages the cancer risk. Prenetics Global Limited is based in Quarry Bay, Hong Kong.


Note : All Data Generated at the End of Trading Hours (EOD Data)